DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Asuragen, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-651-0191 Fax: 512-721-4859


SEARCH JOBS










 Company News
Asuragen, Inc.’s Xpansion Interpreter® Test Study Of 1,040 Transmissions Of Fragile X Alleles Reveals Personalized Risks For Expansion From Parent To Child 9/17/2014 11:03:45 AM
Company Profile For Asuragen, Inc. 8/15/2014 10:44:49 AM
Asuragen, Inc. Names Matthew McManus, M.D., Ph.D., President And CEO 8/5/2014 10:26:29 AM
Asuragen, Inc. Receives New York State License For Molecular Genetic And Oncology Clinical Laboratory Testing 7/10/2014 6:20:01 AM
Asuragen, Inc. Receives Notice of Patent Allowance for Broad Diagnostic Application of miR-21 in Cancer 10/8/2013 10:08:52 AM
Exiqon A/S and Asuragen, Inc. Sign Agreement for Real-Time PCR Services 6/10/2013 9:38:14 AM
Asuragen, Inc. Launches SuraSeq™ Next Generation Sequencing Panel in Its CAP Accredited CLIA Laboratory 5/30/2013 11:04:26 AM
Asuragen, Inc. Launches SuraSeq™ Next Generation Sequencing Services 4/4/2013 11:52:14 AM
Asuragen, Inc. Study Finds New Genetic Test Better Predicts Mother's Risk of Having a Child With Fragile X Syndrome 3/21/2013 11:20:15 AM
Asuragen, Inc. Collects $7.5 Million Financing 3/21/2013 9:20:34 AM
123456789